Studies of therapy | |||
---|---|---|---|
Level | Risk of bias | Study design | Criteria |
I |
Low risk
Study adheres to commonly held tenets of high quality design, execution and avoidance of bias |
Good quality RCT | • Random sequence generation • Allocation concealment • Intent-to-treat analysis • Blind or independent assessment for important outcomes • Co-interventions applied equally • F/U rate of 80%+ • Adequate sample size |
II |
Moderately low risk
Study has potential for some bias; study does not meet all criteria for level I, but deficiencies not likely to invalidate results or introduce significant bias |
Moderate or poor quality RCT Good quality cohort |
• Violation of one of the criteria for good quality RCT • Blind or independent assessment in a prospective study, or use of reliable dataa in a retrospective study • Co-interventions applied equally • F/U rate of 80%+ • Adequate sample size • Controlling for possible confoundingb |
III |
Moderately high risk
Study has significant flaws in design and/or execution that increase potential for bias that may invalidate study results |
Moderate or poor quality cohort Case-control |
• Violation of any of the criteria for good quality cohort • Any case-control design |
IV |
High risk
Study has significant potential for bias; lack of comparison group precludes direct assessment of important outcomes |
Case series | • Any case series design |
Outcome assessment is independent of healthcare personnel judgment. Reliable data are data such as mortality or re-operation.
Authors must provide a description of robust baseline characteristics, and control for those that are unequally distributed between treatment groups.